Term Framework for the Provision of Chemistry Synthesis and other Chemistry Services Outsourcing Framework
A Modification Notice
by UNIVERSITY OF DUNDEE
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- 4 year
- Value
- £4M
- Sector
- PROFESSIONAL
- Published
- 29 Nov 2024
- Delivery
- To 29 Nov 2028 (est.)
- Deadline
- n/a
Concepts
Location
Biological Chemistry & Drug Discovery (BCDD), University of Dundee
3 buyers
- Dundee University Dundee
11 suppliers
- Bioascent Discovery Newhouse
- Chemveda Life Sciences India Telangana
- 3Xper Innoventure Tamil Nadu
- Cambridge Bioscience Cambridge
- Sai Life Sciences Macclesfield
- Enamine Sia Riga
- Jubilant Biosys Bangalore
- Chempartner Europe Aps Copenhagen
- Syngene Bangalore
- TCG Lifesciences West Bengal
- Wuxi Apptec London
Description
This Second-Generation Framework is required to provide a quick route to market for the provision of Chemistry Synthesis and other Chemistry Services. The initial contract term will be two (2) years, with the option to extend for 2 x 12 months, if required, at the sole discretion of BCDD and subject to ongoing satisfactory performance by the appointed Service Providers The Chemistry Synthesis and Other Chemistry Services required will include: 1. FTE rate for provision of chemistry support for medicinal chemistry programme(s), typically making 50mg samples of compounds for initial biological evaluation. For actives, re-synthesis on a larger scale may be required (typically 0.5g to 5g scale). The ability to carry out array chemistry is important; 2. Bespoke piece(s) of chemistry e.g. synthesis of a defined list of compounds, typically at <50mg scale; -Scale up of chemistry, up to 200g; -Chiral separation by crystallization or SFC/Chiral HPLC on (up to) gram scale. -Synthesis of intermediates at 5-100g; For all of these, a purity level will be defined. This will depend on the phase of the project, but typically is >95% purity and for scale up> 98% purity with no impurity >0.5%; -Experimental write-ups, when requested, including compound characterization by 1H NMR, 13C NMR and LCMS or UPLC/MS for publications, in-vivo release, tech-transfer to DDU or other CRO for patent purposes. The subsequent route to market will be via Mini Comp under the Framework.
Ammendments to Previous Notice
2. Contract value
GBP 1,000,000 4,000,000
Award Detail
1 | Bioascent Discovery (Newhouse)
|
2 | Chemveda Life Sciences India (Telangana)
|
3 | 3Xper Innoventure (Tamil Nadu)
|
4 | Cambridge Bioscience (Cambridge)
|
5 | Sai Life Sciences (Macclesfield)
|
6 | Enamine Sia (Riga)
|
7 | Jubilant Biosys (Bangalore)
|
8 | Chempartner Europe Aps (Copenhagen)
|
9 | Syngene (Bangalore)
|
10 | TCG Lifesciences (West Bengal)
|
11 | Wuxi Apptec (London)
|
CPV Codes
- 73110000 - Research services
Indicators
- Contract modified due to additional needs.
Legal Justification
As per above
Other Information
(SC Ref:784551)
Reference
- FTS 038621-2024